SR-A3 suppresses AKT activation to protect against MAFLD by inhibiting XIAP-mediated PTEN degradation
Pingping Lai(Peking University), Xunde Xian(Home Office), Guolin Miao(Home Office), Lianxin Zhang(Peking University), Gonglie Chen(Peking University), Yitong Xu(Peking University), Ying Zhao(Western University), Jingxuan Chen(Henan University of Technology), Xiaoguang Dou(China Medical University), Jinxuan Chen(Peking University), Si Mei(Hunan University of Traditional Chinese Medicine), Xin Guo(Ganzhou People's Hospital), Shengmei Wen, Dongyu Zhao(Peking University), Guanghou Shui(Chinese Academy of Sciences), Yuhui Wang(Peking University), Chong Zhang(Zhejiang University), Jiabao Guo(Peking University), Yang Ding(China Medical University), Yiran Liu(Peking University), Luzheng Xu(Peking University), Wenxi Zhang(Peking University), Zihao Zhou(Wuhan University), Yufei Han(Peking University), Wei Huang(Peking University), Yanwei Li(Tibet Autonomous Region People's Hospital), Sin Man Lam(LipidALL Technologies (China))
Cited by 8
Related Papers
Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor
|Pharmacological Research|2020|393
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
Hydrogen Sulfide Induces Keap1 S-sulfhydration and Suppresses Diabetes-Accelerated Atherosclerosis via Nrf2 Activation
|Diabetes|2016|334
A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19
|Nature Metabolism|2021|298
Harnessing the intracellular triacylglycerols for titer improvement of polyketides in Streptomyces
|Nature Biotechnology|2019|223